Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Wanbury

Sector: Healthcare | Industry: Drugs & Pharma
R 15.95 0.75  | 4.93% -22.95% - 36.46
NSE Price: Nov 19, 15:32 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 19, 15:32 15.95 0.75 4.93% 15.95 15.20 6,894 15.90 - 15.95
BSE Nov 19, 2019 15.37 0.73 4.99% 15.37 14.64 2,201 15.37 - 15.37
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX

Back to Top


Directors' Report

As on Mar-18
Download PDF

Management Discussion

As on Mar-18
Download PDF

Corporate Governance

As on Mar-18
Download PDF

Auditors' Report

As on Mar-18
Download PDF

Notes to Accounts Statement

As on Mar-18
Download PDF
Essential checks
Altman Z-Score
-0.37
Piotroski F-Score
7
Modified C-Score
2
3-Years Price to Earnings
Not available
3-Years Price to Book
-0.20
Earnings Yield
EBIT / Enterprise value
13.24%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,600.65 -1.24%
Caplin Point Laboratories R346.85 -2.12%
Eris Lifesciences R422.55 +2.44%
FDC R198.50 +2.37%
Granules India R128.55 +0.23%
Laurus Labs R341.20 +1.11%
Strides Pharma Science R381.05 +0.29%
Sun Pharma Adv. Research R153.50 -0.81%
Suven Life Sciences R302.95 +0.41%
Wockhardt R288.70 -2.68%
As on Nov 19, 15:59